AI Verdict
MSFT has stronger fundamentals based on our AI analysis.
REGN vs MSFT Fundamental Comparison
| Metric | REGN | MSFT |
|---|---|---|
| Revenue | $14.3B | $158.9B |
| Net Income | $4.5B | $66.2B |
| Net Margin | 31.4% | 41.7% |
| ROE | 14.4% | 16.9% |
| ROA | 11.1% | 10.0% |
| Current Ratio | 4.13x | 1.39x |
| Debt/Equity | 0.06x | 0.10x |
| EPS | $41.48 | $8.87 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
REGN vs MSFT: Frequently Asked Questions
Is REGN or MSFT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MSFT has stronger fundamentals. REGN is rated BUY (80% confidence) while MSFT is rated BUY (91% confidence). This is not investment advice.
How does REGN compare to MSFT fundamentally?
REGENERON PHARMACEUTICALS, INC. has ROE of 14.4% vs MICROSOFT CORP's 16.9%. Net margins are 31.4% vs 41.7% respectively.
Which stock pays higher dividends, REGN or MSFT?
REGN has a dividend yield of N/A or no dividend while MSFT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in REGN or MSFT for long term?
For long-term investing, consider that REGN has BUY rating with 80% confidence, while MSFT has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about REGN vs MSFT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For REGN vs MSFT, the AI consensus favors MSFT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.